| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 65.917 | 152.738 | 183.298 | 228.670 | 222.642 |
| Total Income - EUR | - | - | - | - | - | 65.917 | 152.738 | 183.298 | 228.698 | 222.668 |
| Total Expenses - EUR | - | - | - | - | - | 57.145 | 138.660 | 165.685 | 203.764 | 205.642 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 8.772 | 14.078 | 17.613 | 24.934 | 17.026 |
| Net Profit/Loss - EUR | - | - | - | - | - | 8.113 | 11.564 | 15.780 | 22.692 | 10.715 |
| Employees | - | - | - | - | - | 1 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Olga Transmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 39.144 | 40.927 | 45.681 | 47.385 | 32.885 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 14.453 | 6.235 | 25.090 | 10.205 | 25.232 |
| Cash | - | - | - | - | - | 24.691 | 34.692 | 20.592 | 37.180 | 7.653 |
| Shareholders Funds | - | - | - | - | - | 29.137 | 40.055 | 43.793 | 42.092 | 25.030 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 5.066 |
| Debts | - | - | - | - | - | 10.007 | 872 | 1.889 | 5.293 | 7.855 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7912 - 7912" | |||||||||
| CAEN Financial Year |
7810
|
|||||||||
Comments - Olga Transmed Srl